Carcinogenic and anticarcinogenic effects of dehydroepiandrosterone in the liver of male and female rats

Aging Male

Volumn 1, Issue 1, 1998, Pages 56-66

  Mayer, D ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Cancer prevention; Dehydroepiandrosterone; Enhancement of tumor growth; Hepatocarcinogenesis; Lipid peroxidation; Liver; Metabolism; Mitochondria; Organ specificity; Peroxisomes; Rat; Sex specificity

Indexed keywords

EID: 0002508312     PISSN: 13685538     EISSN: None     Source Type: Journal    
DOI: 10.3109/13685539809148603     Document Type: Article

References (63)

1. Baulieu EE. Studies of conjugated 17-ketosteroids in a case of adrenal tumor. J Clin Endocrinol Metab 1962;22:501-10
2. Orentreich N, Brind JL, Rizer RL, Vogelman JH. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 1984;59:551-5
3. Schwartz AG, Whitcomb JM, Nyce JW, Lewhart ML, Pashko LL. Dehydroepiandrosterone and structural analogs: a new class of cancer chemopreventive agents. Adv Cancer Res, 1988:51: 391-424
4. Ebeling P, Kovisto VA. Physiological importance of dehydroepiandrosterone. Lancet 1994;343:1479-81
5. Bellino FL, Daynes RA, Hornsby PJ, Lavrin DH, Nestler JE, eds. Dehydroepiandrosterone (DHEA) and aging. Ann NY Acad Sci 1995;774:1-350
6. Gordon GB, Shantz LM, Talalay P. Modulation of growth differentiation and carcinogenesis by dehydroepiandrosterone. Adv Enzyme Regul 1987;26: 355-82
7. Mayer D, Weber E, Bannasch P. Modulation of liver carcinogenesis by dehydroepiandrosterone. In Kalimi M, Regelson W, eds. The Biologic Role of Dehydroepiandrosterone (DHEA). Berlin, Germany: Walter de Gruyter, 1990;361-85
8. Metzger C, Mayer D, Hoffmann H, Bocker T, Hobe G, Benner A, Bannasch P. Sequential appearance and ultrastructure of amphophilic cell foci, adenomas, and carcinomas in the liver of male and female rats treated with dehydroepiandrosterone. Toxicol Pathol 1995;23:591-605
9. Weber G. Enzymology of cancer cells, Parts 1 and 2. N Engl J Med 1977;296:486-93, 541-51
10. Klimek F, Mayer D, Bannasch P. Biochemical microanalysis of glycogen content and glucose-6-phosphate dehydrogenase activity in focal lesions of the rat liver induced by N-nitrosomorpholine. Carcinogenesis 1984;5:265-8
11. Stumpf H, Bannasch P. Overexpression of glucose-6-phosphate dehydrogenase in rat hepatic preneoplasia and neoplasia. Int J Oncol 1994;5:1255-60
12. Van Werden EM, Bierings HG, van Steenbrugge GJ, de Jong FH, Schröder FH. Adrenal glands of the mouse and rat do not synthesize androgens. Life Sci 1992;50:857-61
13. Hamilton SR, Gordon GB, Floyd J, Golightly S. Evaluation of dietary dehydroepiandrosterone for chemoprotection against tumorigenesis in premalignant colonic epithelium of male F 344 rats. Cancer Res 1991;51:476-80
14. Hobe G, Hillesheim HG, Schön R, Reddersen G, Knappe R, Bannasch P, Mayer D. Sex differences in dehydroepiandrosterone metabolism in the rat: different plasma levels following ingestion of DHEA-supplemented diet and different metabolite patterns in plasma, bile and urine. Horm Metab Res 1994;26:326-9
15. Sonka J. Dehydroepiandrosterone: metabolic effects. Acta Univ Carol Med 1976;71:1-171
16. Leighton B, Tagliaferro AR, Newsholme EA. The effect of dehydroepiandrosterone acetate on liver peroxisomal enzyme activities of male and female rats. J Nutr 1987;117:1287-90
17. Cleary MP, Shepherd A, Zisk J, Schwartz A. Effects of dehydroepiandrosterone on body weight and food intake in rats. Nutr Behav 1983;1:127-36
18. Cleary MP, Hood SS, Chando C, Hansen CT, Billheimer JT. Response of sucrose-fed BHE rats to dehydroepiandrosterone. Nutr Res 1984;4:485-94
19. Cleary MP, Shepherd A, Jenks B. Effect of dehydroepiandrosterone on growth in lean and obese Zucker rats. J Nutr 1984;114:1242-51
20. Cleary MP. Effect of dehydroepiandrosterone treatment on liver metabolism in rats. Int J Biochem 1990;22:205-10
21. Mayer D, Reuter S, Hoffmann H, Bocker T, Bannasch P. Dehydroepiandrosterone reduces expression of glycolytic and gluconeogenic enzymes in the liver of male and female rats. Int J Oncol 1996;8:1069-78
22. Mayer D, Weber E, Moore MA, Letsch I, Filsinger E, Bannasch P. Dehydroepiandrosterone (DHEA) induced alterations in rat liver carbohydrate metabolism. Carcinogenesis 1988;11:2039-49
23. Hobe G, Hillesheim HG, Schön R, Ritter P, Reddersen G, Mayer D, Bannasch P. Sex differences in dehydroepiandrosterone (DHEA) metabolism in the rat. In Görög S, ed. Proceedings of the 5th Symposium on Analysis of Steroids. Budapest, Hungary: Akademiai Kiado, 1994;383-90
24. vy/a) mice by long-term treatment with dehydroepiandrosterone. Cancer Res 1979;15:1269-74
25. Ratko TA, Detrisac CJ, Mehta RG, Kelloff GJ, Moon RC. Inhibition of rat mammary gland chemical carcinogenesis by dietary dehydroepiandrosterone or a fluorinated analogue of dehydroepiandrosterone. Cancer Res 1991;51:481-6
26. Li S, Yan X, Bélanger A, Labrie F. Prevention by dehydroepiandrosterone of the development of mammary carcinoma induced by 7,12-dimethylbenzanthracene (DMBA) in the rat. Breast Cancer Res Treat 1993;29:203-17
27. McCormick DL, Rao KVN, Johnson WD, Bowman-Gram TA, Steele VE, Lubet RA, Kelloff GJ. Exceptional chemopreventive activity of low-dose dehydroepiandrosterone in the rat mammary gland. Cancer Res 1996;56:1724-6
28. Pashko LL, Rovito RT, Williams JR, Sobel EL, Schwartz AG. Dehydroepiandrosterone (DHEA) and 3β-methylandrost-5-en-17-one: inhibitors of 7,12-dimethylbenz[a]anthracene (DMBA)-initiated and 12-O-tetradecanoyl-phorbol-13-acetate (TPA)-promoted skin papilloma formation in mice. Carcinogenesis 1984;5:463-6
29. Schwartz AG, Fairman DK, Polansky M, Lewbart ML, Pashko LL. Inhibition of 7,12-dimethylbenz[a]anthracene-initiated and 12-O-tetradecanoylphorbol-13-acetate-promoted skin papilloma formation in mice by dehydroepiandrosterone and two synthetic analogs. Carcinogenesis 1989;10: 1809-13
30. Nyce JW, Magee PN, Hard GC, Schwartz AG. Inhibition of 1,2-dimethylhydrazine-induced colon tumorigenesis in Balb/c mice by dehydroepiandrosterone. Carcinogenesis 1984;5:57-62
31. Schwartz AG, Tannen RH. Inhibition of 7,12-dimethylbenz[a]anthracene and urethane-induced lung tumor formation in A/J mice by long-term treatment with dehydroepiandrosterone. Carcinogenesis 1981;2:1335-7
32. Moore MA, Thamavit W, Tsuda H, Sato K, Ichihara A, Ito N. Modifying influence of dehydroepiandrosterone on the development of dihydroxy-di-n-propylnitrosamine-initiated lesions in the thyroid, lung and liver of F344 rats. Carcinogenesis 1986;7:311-16
33. Bannasch P. Pathogenesis of hepatocellular carcinoma: sequential cellular, molecular, and metabolic changes. In Boyer JL, Ockner RK, eds. Progress in Liver Disease. Philadelphia, USA: WB Saunders Company, 1996;XIV:161-97
34. Weber E, Moore MA, Bannasch P. Enzyme histochemical and morphological phenotype of amphophilic foci and amphophilic/tigroid cell adenomas in rat liver after combined treatment with dehydroepiandrosterone and N-nitrosomorpholine. Carcinogenesis 1988;9:1049-54
35. Bannasch P, Klimek F, Mayer D. Early bioenergetic changes in hepatocarcinogenesis: preneoplastic phenotypes mimic responses to insulin and thyroid hormone. J Bioenerg Biomemb 1997;29: 303-13
36. Garcea R, Daino L, Pascale R, Frassetto S, Cozzolino P, Ruggiu ME, Feo F. Inhibition by dehydroepiandrosterone of liver preneoplastic foci formation in rats after initiation-selection in experimental carcinogenesis. Toxicol Pathol 1987;15: 164-9
37. Garcea R, Daino L, Frassetto S, Cozzolino P, Ruggiu ME, Vannini MG, Pascale R, Lenzerini L, Simile MM, Puddu M, Feo F. Reversal by riboand deoxyribonucleosides of dehydroepiandrosterone-induced inhibition of enzyme altered foci in the liver of rats subjected to the initiation-selection process of experimental hepatocarcinogenesis. Carcinogenesis 1988;9:931-8
38. Thornton M, Moore MA, Ito N. Modifying influence of dehydroepiandrosterone or butylated hydroxytoluene treatment on initiation and development stages of azaserine-induced acinar pancreatic lesions in the rat. Carcinogenesis 1989;10:407-10
39. Weber E, Moore M, Bannasch P. Phenotypic modulation of hepatocarcinogenesis and reduction in N-nitrosomorpholine-induced hemangiosarcoma and adrenal lesion development in Sprague-Dawley rats by dehydroepiandrosterone. Carcinogenesis 1988;9:1191-5
40. Moore MA, Weber E, Bannasch P. Modulating influence of dehydroepiandrosterone administration on the morphology and enzyme phenotype of dimethylaminoazobenzene-induced hepatocellular foci and nodules. Virchows Arch B Cell Pathol 1988;55:337-43
41. Rao MS, Subbarao V, Kumar S, Yeldandi V, Reddy JK. Phenotypic properties of liver tumors induced by dehydroepiandrosterone in F-344 rats. Jpn J Cancer Res 1992;83:1179-83
42. Rao MS, Subbarao V, Yeldandi AV, Reddy JK. Hepatocarcinogenicity of dehydroepiandrosterone in the rat. Cancer Res 1992;52:2977-9
43. Hayashi F, Tamura H, Yamada J, Kasai H, Suga T. Characteristics of the hepatocarcinogenesis caused by dehydroepiandrosterone, a peroxisome proliferator, in male F-344. rats. Carcinogenesis 1994; 15:2215-19
44. Metzger C, Bannasch P, Mayer D. Enhancement and phenorypic modulation of N-nitrosomorpholine-induced hepatocarcinogenesis by dehydroepiandrosterone. Cancer Letters 1998;in press
45. Moore MA, Weber E, Thornton M, Bannasch P. Sex-dependent, tissue-specific opposing effects of dehydroepiandrosterone on initiation and modulation stages of liver and lung carcinogenesis induced by dihydroxy-di-n-propylnitrosamine in F344 rats. Carcinogenesis 1988;9:1507-9
46. Ogiu T, Hard GC, Schwartz AG, Magee PN. Investigation into the effect on renal carcinogenesis induced in the rat by a single dose of DMN. Nutr Cancer 1990;14:57-67
47. Reuter S, Mayer D. Transport of dehydroepiandrosterone and dehydroepiandrosterone sulphate into rat hepatocytes. J Steroid Biochem Molec Biol 1995;54:227-35
48. Swierczynski J, Bannasch P, Mayer D. Increase of lipid peroxidation in rat liver microsomes by dehydroepiandrosterone feeding. Biochim Biophys Acta 1996;1315:193-8
49. Swierczynski J, Mayer D. Dehydroepiandrosterone-induced lipid peroxidation in rat liver mitochondria. J Steroid Biochem Molec Biol 1996; 58:599-603
50. Swierczynski J, Kochan Z, Mayer D. Dietary α-tocopherol prevents dehydroepiandrosterone-induced lipid peroxidation in rat liver microsomes and mitochondria. Toxicol Letters 1997;91:129-36
51. LAω) by dehydroepiandrosterone in rats: a possible peroxisome proliferator. Cancer Res 1989;49:2337-43
52. Prough RA, Webb SJ, Wu H-Q, Lapenson DP, Waxman DJ. Induction of microsomal and peroxisomal enzymes by dehydroepiandrosterone and its reduced metabolite in rats. Cancer Res 1994;54:2878-86
53. Beier K, Völkl A, Metzger C, Mayer D, Bannasch P, Fahimi HD. Hepatic zonation of the induction of cytochrome P450 IVA, peroxisomal lipid peroxidation enzymes and peroxisome proliferation in rats treated with dehydroepiandrosterone (DHEA). Evidence of distinct zonal and sex-specific differences. Carcinogenesis 1997;18:1491-8
54. Rao MS, Reid B, Ide H, Subbarao V, Reddy JK. Dehydroepiandrosterone-induced peroxisome proliferation in the rat: evaluation of sex differences. Proc Soc Exp Biol Med 1994;207:186-90
55. Frenkel RA, Slaughter CA, Orth K, Moomaw CR, Hicks SH, Snyder JM, Bennet M, Prough RA, Putnam RS, Milewich L. Peroxisome proliferation and induction of peroxisomal enzymes in mouse and rat liver by dehydroepiandrosterone feeding. J Steroid Biochem 1990;35:333-42
56. Yamada J, Sakuma M, Ikeda T, Fukuda K, Suga T. Characteristics of dehydroepiandrosterone as a peroxisome proliferator. Biochim Biophys Acta 1991; 1092:233-43
57. Issemann I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature (London) 1990;347: 645-50
58. Green S. Receptor-mediated mechanisms of peroxisome proliferators. Biochem Pharmacol 1992;43: 393-401
59. Reddy JK, Lalwani ND. Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. Crit Rev Toxicol 1983;12:1-58
60. Hawkins JM, Jones WE, Bonner FW, Gibson GG. The effect of peroxisome proliferators on microsomal, peroxisomal, and mitochondrial enzyme activities in the liver and kidney. Drug Metab Rev 1987;18:441-515
61. Yamada J, Sakuma M, Ikeda T, Suga T. Activation of dehydroepiandrosterone as a peroxisome proliferator by sulfate conjugation. Arch Biochem Biophys 1994;313:379-81
62. Sakuma M, Yamada J, Suga T. Induction of peroxisomal β-oxidation by structural analogues of dehydroepiandrosterone in cultured rat hepatocytes: structure-activity relationships. Biochim Biophys Acta 1993;1169:66-72
63. Yamada J, Sugiyama H, Tamura H, Suga T. Hormonal modulation of peroxisomal enzyme induction caused by peroxisome proliferators: suppression by growth and thyroid hormones in cultured rat hepatocytes. Arch Biochem Biophys 1994;315:555-7